Characterization of new, efficient Mycobacterium tuberculosis topoisomerase-I inhibitors and their interaction with human ABC multidrug transporters-Reference-Cited by-同舟云学术

Characterization of new, efficient Mycobacterium tuberculosis topoisomerase-I inhibitors and their interaction with human ABC multidrug transporters

Published:2018-09-05 Issue:9 Volume:13 Page:e0202749
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Temesszentandrási-Ambrus Csilla,Tóth Szilárd,Verma Rinkee,Bánhegyi Péter,Szabadkai István,Baska Ferenc,Szántai-Kis Csaba,Hartkoorn Ruben C.,Lingerfelt Mary A.,Sarkadi Balázs,Szakács Gergely,Őrfi László,Nagaraja Valakunja,Ekins Sean,Telbisz Ágnes^ORCID

Funder

NRDIO, Hungary

Department of Science and Technology, Government of India

NRDIO

FP7 Ideas: European Research Council

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference35 articles.

1. The complex evolution of antibiotic resistance in Mycobacterium tuberculosis;JD Fonseca;International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases,2015

2. Development of efflux pump inhibitors in antituberculosis therapy;L Song;International journal of antimicrobial agents,2016

3. Inhibitory potential of tuberculosis drugs on ATP-binding cassette drug transporters;LH Te Brake;Tuberculosis (Edinburgh, Scotland),2016

4. Involvement of breast cancer resistance protein (ABCG2) in the biliary excretion mechanism of fluoroquinolones;T Ando;Drug metabolism and disposition: the biological fate of chemicals,2007

5. Relative contributions of active mediated transport and passive diffusion of fluoroquinolones with various lipophilicities in a Calu-3 lung epithelial cell model;J Brillault;Antimicrobial agents and chemotherapy,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lysocin E Targeting Menaquinone in the Membrane of Mycobacterium tuberculosis Is a Promising Lead Compound for Antituberculosis Drugs;Antimicrobial Agents and Chemotherapy;2022-09-20

2. Type IA Topoisomerases as Targets for Infectious Disease Treatments;Microorganisms;2021-01-01

3. Mycobacterium tuberculosis topoisomerases and EthR as the targets for new anti-TB drugs development;Future Medicinal Chemistry;2019-08

4. Identification of anticancer OATP2B1 substrates by an in vitro triple-fluorescence-based cytotoxicity screen;Archives of Toxicology;2019-03-12